Free Trial

AC Immune (ACIU) Stock Price, News & Analysis

AC Immune logo
$2.14 +0.06 (+2.88%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.17 +0.03 (+1.40%)
As of 08/8/2025 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About AC Immune Stock (NASDAQ:ACIU)

Key Stats

Today's Range
$2.07
$2.19
50-Day Range
$1.65
$2.45
52-Week Range
$1.43
$3.98
Volume
97,918 shs
Average Volume
163,494 shs
Market Capitalization
$214.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

AC Immune Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

ACIU MarketRank™: 

AC Immune scored higher than 40% of companies evaluated by MarketBeat, and ranked 679th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AC Immune has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AC Immune has received no research coverage in the past 90 days.

  • Read more about AC Immune's stock forecast and price target.
  • Earnings Growth

    Earnings for AC Immune are expected to grow in the coming year, from ($0.62) to ($0.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AC Immune is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AC Immune is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AC Immune has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.29% of the float of AC Immune has been sold short.
  • Short Interest Ratio / Days to Cover

    AC Immune has a short interest ratio ("days to cover") of 10.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AC Immune has recently decreased by 0.71%, indicating that investor sentiment is improving.
  • Dividend Yield

    AC Immune does not currently pay a dividend.

  • Dividend Growth

    AC Immune does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.29% of the float of AC Immune has been sold short.
  • Short Interest Ratio / Days to Cover

    AC Immune has a short interest ratio ("days to cover") of 10.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AC Immune has recently decreased by 0.71%, indicating that investor sentiment is improving.
  • News Sentiment

    AC Immune has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for AC Immune this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for ACIU on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AC Immune insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of AC Immune is held by insiders.

  • Percentage Held by Institutions

    51.36% of the stock of AC Immune is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AC Immune's insider trading history.
Receive ACIU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AC Immune and its competitors with MarketBeat's FREE daily newsletter.

ACIU Stock News Headlines

AC Immune Reports Q2 2025 Financial Progress
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.
ACIU AC Immune SA - Seeking Alpha
AC Immune SA (ACIU) - Yahoo Finance
See More Headlines

ACIU Stock Analysis - Frequently Asked Questions

AC Immune's stock was trading at $2.70 at the beginning of the year. Since then, ACIU stock has decreased by 20.7% and is now trading at $2.14.

AC Immune (NASDAQ:ACIU) issued its quarterly earnings data on Tuesday, August, 5th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.05. The business earned $1.65 million during the quarter, compared to analyst estimates of $1.98 million. AC Immune had a negative trailing twelve-month return on equity of 49.35% and a negative net margin of 174.94%.

AC Immune (ACIU) raised $55 million in an initial public offering (IPO) on Friday, September 23rd 2016. The company issued 4,600,000 shares at a price of $11.00-$13.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Shares of ACIU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AC Immune investors own include Meta Platforms (META), NVIDIA (NVDA), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Tesla (TSLA), Advanced Micro Devices (AMD) and Canopy Growth (CGC).

Company Calendar

Last Earnings
8/05/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACIU
CIK
1651625
Employees
140
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$12.00
Potential Upside/Downside
+460.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.83 million
Net Margins
-174.94%
Pretax Margin
-176.80%
Return on Equity
-49.35%
Return on Assets
-23.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.33
Quick Ratio
1.53

Sales & Book Value

Annual Sales
$31.02 million
Price / Sales
6.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.90 per share
Price / Book
2.38

Miscellaneous

Outstanding Shares
100,410,000
Free Float
95,791,000
Market Cap
$214.88 million
Optionable
Optionable
Beta
1.65
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ACIU) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners